Douglas Baum
Directeur/Membre du Conseil chez Regent GLSC Technologies, Inc.
Fortune : 5 534 $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| David Arthur Nelson | M | 76 |
Regent GLSC Technologies, Inc.
 Regent GLSC Technologies, Inc. Medical SpecialtiesHealth Technology Part of Regent Technologies, Inc., Regent GLSC Technologies, Inc. is a company that manufactures medical equipment. The company is based in Dallas, TX. David Arthur Nelson has been the CEO of the company since 2007. | 17 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Christopher Nelson | M | 54 | 20 ans | |
| Steven Pieper | M | 47 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | - |
| Kevin M. Bolin | M | 60 | 4 ans | |
| Namrata Chand | F | 43 | - | |
| Paul Edick | M | 67 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | - |
| Adriann Sax | F | 63 | 2 ans | |
| Adam King | M | 39 | 3 ans | |
| Scott W. Whitney | M | 67 | 5 ans | |
| Tristan Anthony Peitz | M | 40 | 3 ans | |
| Jeffrey Soinski | M | 61 | - | |
| C. Piazza | M | 77 | 20 ans | |
| Joel D. Mayersohn | M | 66 | 8 ans | |
| Jonathan Rigby | M | 56 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 ans |
| Charles Link | M | 64 | 3 ans | |
| Michelle Murcia | F | 56 | 3 ans | |
| Arthur W. Batson | M | 64 | - | |
| David Shields | M | - | - | |
| Sudheer M. Pimputkar | M | 74 | 1 ans | |
| Christopher J. Spencer | M | 55 | 2 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 20 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Douglas Baum
- Réseau Personnel
